Correction: Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases (Journal of Medicinal Chemistry (2020) 63:13 (7033−7051) DOI: 10.1021/acs.jmedchem.0c00366)

Xiawei Dang, Lihong Zhang, Antonietta Franco, Jiajia Li, Agostinho G. Rocha, Sriram Devanathan, Roland E. Dolle, Peter R. Bernstein, Gerald W. Dorn

Research output: Contribution to journalComment/debate

Abstract

Page 7046. In paragraph 2, lines 15.21, column 2 should be LC-MS: Rt = 0.719 min, m/z = 275.1 (M +H)+. 1H NMR: 400 MHz MeOD : 7.25.7.22 (m, 2H), 7.17.7.13 (m, 3H), 3.81.3.76 (m, 1H), 3.14.3.11 (m, 2H), 2.79.2.78 (m, 2H), 2.76.2.75 (m, 2H), 2.60 (t, J = 7.2 Hz, 2H), 2.16 (t, J = 7.2 Hz, 2H).

Original languageEnglish
Pages (from-to)10086
Number of pages1
JournalJournal of Medicinal Chemistry
Volume63
Issue number17
DOIs
StatePublished - Sep 10 2020

Fingerprint Dive into the research topics of 'Correction: Discovery of 6-Phenylhexanamide Derivatives as Potent Stereoselective Mitofusin Activators for the Treatment of Mitochondrial Diseases (Journal of Medicinal Chemistry (2020) 63:13 (7033−7051) DOI: 10.1021/acs.jmedchem.0c00366)'. Together they form a unique fingerprint.

Cite this